Morgan Stanley Maintains Equal-Weight on Treace Medical Concepts, Raises Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Drew Ranieri maintains an Equal-Weight rating on Treace Medical Concepts (NASDAQ:TMCI) and raises the price target from $5.5 to $8.
July 15, 2024 | 5:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained its Equal-Weight rating on Treace Medical Concepts and raised the price target from $5.5 to $8.
The raised price target from $5.5 to $8 by a reputable analyst at Morgan Stanley is a positive signal for investors, indicating potential upside. However, the Equal-Weight rating suggests a balanced view, hence the moderate positive impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100